As shown in Figure 5a,b, the AMS group exhibited significantly elevated expression of HIF-1α, VEGFA, and EPO and an increased Bax/Bcl-2 ratio in lung tissue compared to the Normal group. The gene discussed is BCL2; the disease is ablepharon macrostomia syndrome.